Novosti

Ceres Pharma Romania has signed two new partnerships for the marketing and distribution of interesting brands in the Romanian market: one with Karo Healthcare AB and the other for the Scholl footcare range.

From 1 October 2024, all Ceres Pharma affiliates changed their local company name to Ceres Pharma.

Ceres Pharma NV, a Belgian based pharmaceutical company, active in Women’s and Family Health, has reached an agreement to acquire 100% of the shares of the Italian pharmaceutical company Aesculapius Farmaceutici  S.r.l.

Ceres Pharma NV, a Belgian based pharmaceutical company, active in Women’s and Family Health, has acquired the Hungarian pharmaceutical company VitaPlus Kft, including Innopharm Kft.

Ceres Pharma NV, a Belgian based pharmaceutical company, active in Women and Family Healthcare, has acquired the Italian pharmaceutical group Amnol S.r.l.

Ceres Pharma reached an agreement with Dovesco to acquire 100% of the shares of Labophar. Simultaneously Dovesco will re-invest its proceeds in Ceres Pharma.

Ceres Pharma, a Belgian based dynamic and fast growing pharmaceutical company, active in Women’s and Family Health, has come to an agreement for the acquisition of the Romanian firm Dacia Plant.

Belgian based Ceres Pharma, a dynamic and fast growing pharmaceutical company, active in healthcare & well-being, has completed the acquisition of GlobiFer Intl.

Naxicap Partners acquires Ceres Pharma NV from Alychlo NV & co-founder Mario Debel who will lead this new phase of growth as CEO and shareholder.

Belgian based Ceres Pharma, a dynamic and fast-growing pharmaceutical company, active in healthcare & well-being, has completed the acquisition of the Bulgarian firm, ABOPharma. The price of the takeover will not be disclosed.